| Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 634 | 2017 |
| Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study VK Morris, ME Salem, H Nimeiri, S Iqbal, P Singh, K Ciombor, B Polite, ... The Lancet Oncology 18 (4), 446-453, 2017 | 386 | 2017 |
| Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics WC Foo, MW Cruise, MR Wick, JL Hornick American journal of clinical pathology 135 (6), 839-844, 2011 | 219 | 2011 |
| The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma C Liu, R Karam, YQ Zhou, F Su, Y Ji, G Li, GT Xu, LX Lu, CR Wang, ... Nature medicine 20 (6), 596-598, 2014 | 161 | 2014 |
| Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ... Cancer Cell 40 (5), 509-523. e6, 2022 | 139 | 2022 |
| Prognostic significance of new AJCC tumor stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy D Chatterjee, MH Katz, WC Foo, M Sundar, H Wang, GR Varadhachary, ... The American journal of surgical pathology 41 (8), 1097-1104, 2017 | 76 | 2017 |
| Pathology of gastrointestinal stromal tumors WC Foo, B Liegl-Atzwanger, AJ Lazar Clinical Medicine Insights: Pathology 5, CPath. S9689, 2012 | 70 | 2012 |
| Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal V Morris, X Rao, C Pickering, WC Foo, A Rashid, K Eterovic, T Kim, ... Molecular Cancer Research 15 (11), 1542-1550, 2017 | 69 | 2017 |
| Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer K Ludford, R Cohen, M Svrcek, WC Foo, R Colle, Y Parc, JV Thomas, ... JNCI: Journal of the National Cancer Institute 113 (2), 208-211, 2021 | 67 | 2021 |
| Neoadjuvant pembrolizumab in localized microsatellite instability high/deficient mismatch repair solid tumors K Ludford, WJ Ho, JV Thomas, KPS Raghav, MB Murphy, ND Fleming, ... Journal of Clinical Oncology 41 (12), 2181-2190, 2023 | 62 | 2023 |
| Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, BRAFV600E metastatic colorectal cancer. VK Morris, CM Parseghian, M Escano, B Johnson, KPS Raghav, A Dasari, ... Journal of Clinical Oncology 40 (4_suppl), 12-12, 2022 | 58 | 2022 |
| The immunogenomic landscape of resected intrahepatic cholangiocarcinoma F Carapeto, B Bozorgui, RT Shroff, S Chagani, L Solis Soto, WC Foo, ... Hepatology 75 (2), 297-308, 2022 | 39 | 2022 |
| A positive TGF-β/c-KIT feedback loop drives tumor progression in advanced primary liver cancer A Rojas, P Zhang, Y Wang, WC Foo, NM Muñoz, L Xiao, J Wang, ... Neoplasia 18 (6), 371-386, 2016 | 39 | 2016 |
| FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center C Colombo, WC Foo, D Whiting, ED Young, K Lusby, RE Pollock, ... F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de …, 2012 | 39 | 2012 |
| Lynch syndrome: genomics update and imaging review VL Cox, AA Saeed Bamashmos, WC Foo, S Gupta, S Yedururi, N Garg, ... Radiographics 38 (2), 483-499, 2018 | 38 | 2018 |
| Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma LR Chirieac, YP Hung, WC Foo, MD Hofer, PA VanderLaan, WG Richards, ... Cancer 125 (23), 4164-4171, 2019 | 37 | 2019 |
| Partners in pathology: a collaborative model to bring pathology to resource poor settings JW Carlson, E Lyon, D Walton, WC Foo, AC Sievers, LN Shulman, ... The American journal of surgical pathology 34 (1), 118-123, 2010 | 35 | 2010 |
| Pilot clinical trial of perioperative durvalumab and tremelimumab in the treatment of resectable colorectal cancer liver metastases P Kanikarla Marie, C Haymaker, ER Parra, YU Kim, R Lazcano, S Gite, ... Clinical Cancer Research 27 (11), 3039-3049, 2021 | 32 | 2021 |
| Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma WC Foo, A Rashid, H Wang, MH Katz, JE Lee, PW Pisters, RA Wolff, ... Human pathology 44 (6), 1024-1030, 2013 | 29 | 2013 |
| Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration Y Zhou, YB Medik, B Patel, DB Zamler, S Chen, T Chapman, S Schneider, ... Journal of Experimental Medicine 220 (2), e20221333, 2022 | 25 | 2022 |
ANIRBAN MAITRAProfessor of Translational Molecular Pathology, UT MD Anderson Cancer CenterVerified email at mdanderson.org
